Oct 30, 2020

Featuring a discussion on recent clinical trial data on the use of FLT3 inhibitors in the management of acute myeloid leukemia with Dr Keith Pratz, including the following topics:

• Targeting FLT3 in Acute Myeloid Leukemia (AML) — Keith W Pratz, MD (0:00)
• Case: A man in his late 50s with AML and a FLT3-ITD...

Oct 29, 2020

Featuring perspectives from Dr Arjun Balar, Prof Thomas Powles and Dr Arlene Siefker-Radtke on the following topics:

• Introduction (00:00)
• Immune Checkpoint Inhibitors (00:50)
• Antibody-Drug Conjugates (29:57)
• FGFR-Targeted Therapy (47:07)

CME information and select...

Oct 28, 2020

Proceedings from a CME webinar held in partnership with the American Society of Clinical Oncology. Featuring perspectives from Drs Joyce O’Shaughnessy and Hope S Rugo on the following topics:

• Introduction (0:00)
• Immune checkpoint inhibition (2:36)
• PARP inhibition and other novel agents/strategies (31:16)

CME...

Oct 27, 2020

Featuring a discussion on recent clinical trial data on the use of CAR T-cell therapy in the management of non-Hodgkin lymphoma with Dr Tanya Siddiqi, including the following topics:

• CAR T-Cell Therapy in B-Cell Non-Hodgkin Lymphoma — Tanya Siddiqi, MD (00:00)
• Case: A man in his late 50s with recurrent DLBCL...

Oct 26, 2020

Proceedings from a CME webinar held in partnership with the American Society of Clinical Oncology. Featuring perspectives from Drs Jeff Sharman and Julie M Vose on the following topics:

• Introduction (00:00)
• Chronic Lymphocytic Leukemia (1:49)
• Follicular Lymphoma (37:48)

CME information and select publications